LBR and primary biliary cholangitis: Analysis of the survival rate performed in patients positive and negative for anti-gp210, anti-p62, and anti-LBR (Figure 8) demonstrated that these autoantibodies did not affect the length of life or time to liver transplant in PBC patients.